期刊文献+

盐酸可乐定脉冲释药微丸的制备工艺研究 被引量:5

Study on Preparation Process of Clonidine Hydrochloride Pulsatile Release Pellets
下载PDF
导出
摘要 目的研究盐酸可乐定脉冲释药微丸的制备方法。方法采用挤出-滚圆工艺和流化床包衣法制备,用正交试验设计优化处方,考察产品的体外释放度。结果各考察因素均对药物的释放影响显著。优选工艺结果为,含药丸芯采用微晶纤维素,溶胀层材料采用低取代羟丙纤维素,控释层采用乙基纤维素水分散体,溶胀层和控释层包衣增重分别为10%和15%。制备的微丸时滞时间为4.2 h左右,时滞后1 h内累积释药百分率达到90%。结论盐酸可乐定微丸在体外具有有脉冲释药特性。 Objective To study the preparation of Clonidine Hydrochloride Pulsatile Release Pellets and its in vitro dissolution. Methods Clonidine Hydrochloride Pulsatile Release Pellets was prepared with extrusion-spheronization and fluidized bed coating technology. The formulation was optimized by orthogonal design. The in vitro release of the pellets was determined. Results The drug release was strikingly influenced by various investigation factors. The optimal technology was as follows with microcrystalline cellulose as the pill core containing drug, low-substituted hydroxypropylcellulose for the swelling layer and ethylcellulose aqueous dispersion(surelease) for outer controlled-release layer with 10% and 15% weight increment of coating in swelling layer and controlled-release layer respective- ly. The lag time of prepared pellets was about 4.2 h and the accumulative release rate reached 90% within 1 h. Conclusion Clonidine Hydroehloride Pulsatile Release Pellets has the pulsatile drugrelease characteristic in vitro.
出处 《中国药业》 CAS 2012年第6期44-45,共2页 China Pharmaceuticals
基金 重庆市教育委员会科学技术研究项目 项目编号:KJ092702
关键词 盐酸可乐定 脉冲释药微丸 挤出-滚圆法 流化床包衣 clonidine hydrochloride pulsatile release pellets extrusion- spheronization fluidized bed coating technology
  • 相关文献

参考文献3

二级参考文献35

  • 1平星.浅谈中药微粉的开发应用及存在问题[J].兽药与饲料添加剂,2004,9(4):30-32. 被引量:3
  • 2陈燕忠,张纪兴,吕竹芬.硫酸特布他林脉冲控释微丸的制备[J].中国药科大学学报,2004,35(4):307-310. 被引量:6
  • 3张钧寿.缓/控释制剂的国外研究动向[J].中国新药杂志,1996,5(3):161-164. 被引量:21
  • 4宓静英,杨安金.简述微丸的制备方法[J].江西中医学院学报,2006,18(6):28-28. 被引量:3
  • 5伊藤真次 吴今义.人体昼夜节律[M].重庆出版社,1983.65-68.
  • 6保绍雄.时间药理学与时间治疗学[M].天津:天津科学技术出版社,1993.46-201.
  • 7van den Meiracker A H, Admiraal P J, Janssen J A, et al. Hemodynamic and biochemical effects of the ATl receptor antagonist irbesartan in hypertension [ J ]. Hypertension : Dallas, 1995.25 ( 1 ) :22-29.
  • 8Michel B, Thierry B, Jerome B, et al. Pharmaeokinetic- pharmacodynamic relationships of three angiotensin Ⅱ receptor antagonists in normal volunteers [ J ]. Kidney Int, 1996,55 ( Suppl 55 ) : S24-S29.
  • 9Matsuo M, Arimori K, Nakamura C, et al. Delayed-release tablets using hydroxyethylcellulose as a gel-forming matrix [J]. Int J Pharm,1996,138(4) :225-235.
  • 10罗RC,舍斯基PJ,韦勒PJ.药用辅料手册[M].郑俊民译.北京:化学工业出版社,2005:239-240.

共引文献16

同被引文献57

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部